AGWCA
LUNG icon

Annis Gardner Whiting Capital Advisors’s Pulmonx LUNG Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19
Closed -$177 – 967
2024
Q1 		$177 Buy
+19
New +$223 ﹤0.01% 937

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's LUNG Position: Q2 2024 in Review

Annis Gardner Whiting Capital Advisors sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 19 shares — an estimated $177 sold.

Annis Gardner Whiting Capital Advisors first reported a position in LUNG in Q1 2024 and held it in 1 quarter. The position peaked at $177 in Q1 2024. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Annis Gardner Whiting Capital Advisors reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 19 Pulmonx shares in Q2 2024, an estimated $177.
  • Annis Gardner Whiting Capital Advisors first reported a position in Pulmonx in Q1 2024 and held it in 1 quarter.
  • Annis Gardner Whiting Capital Advisors's Pulmonx position peaked at $177 in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.